Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Quarterly Report · 10-Q

Balchem Corporation

BCPCNASDAQEQUITYCurrent

Quarterly Report

Filed Apr 30, 2026Accepted Apr 30, 2026, 4:33 PM EDTCIK 9326Accession 0000009326-26-000018
Share

Company context

Balchem Corporation develops, manufactures and markets specialty ingredients that improve and enhance the health and well-being of life on the planet, providing state-ofthe-art solutions and the finest quality products for a range of industries worldwide. The company reports three business segments: Human Nutrition & Health; Animal Nutrition & Health; and Specialty Products. The Human Nutrition & Health segment delivers customized food and beverage ingredient systems, as well as key nutrients into a variety of applications across the food, supplement and pharmaceutical industries. The Animal Nutrition & Health segment manufactures and supplies products to numerous animal health markets. Through Specialty Products, Balchem provides specialty-packaged chemicals for use in healthcare and other industries, and also provides chelated minerals to the micronutrient agricultural market.

Current securities

Recent company filings

  1. 10-Q filingJul 31, 2026
  2. Results of Operations and Financial ConditionJul 31, 2026
  3. Entry into a Material Definitive Agreement · Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet ArrangementJul 27, 2026
  4. Submission of Matters to a Vote of Security HoldersJun 22, 2026
  5. 11-K filingJun 18, 2026

As-filed source

Primary evidence